Phillips LR et al. |
Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. |
1995 |
Drug Metab. Dispos. |
pmid:7587953
|
Miyazawa M et al. |
Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. |
2002 |
Drug Metab. Dispos. |
pmid:11950794
|
Prado R et al. |
Nonmelanoma skin cancer chemoprevention. |
2011 |
Dermatol Surg |
pmid:21895847
|
Sarkar S et al. |
Chemoprevention gene therapy (CGT) of pancreatic cancer using perillyl alcohol and a novel chimeric serotype cancer terminator virus. |
2014 |
Curr. Mol. Med. |
pmid:24236457
|
Clark SS et al. |
Anti-leukemia effect of perillyl alcohol in Bcr/Abl-transformed cells indirectly inhibits signaling through Mek in a Ras- and Raf-independent fashion. |
2003 |
Clin. Cancer Res. |
pmid:14555523
|
Stearns V et al. |
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. |
2004 |
Clin. Cancer Res. |
pmid:15569989
|
Ripple GH et al. |
Phase I clinical trial of perillyl alcohol administered daily. |
1998 |
Clin. Cancer Res. |
pmid:9607573
|
Hudes GR et al. |
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies. |
2000 |
Clin. Cancer Res. |
pmid:10955786
|
Ripple GH et al. |
Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day. |
2000 |
Clin. Cancer Res. |
pmid:10690515
|
Gómez-Contreras PC et al. |
In vitro induction of apoptosis in U937 cells by perillyl alcohol with sensitization by pentoxifylline: increased BCL-2 and BAX protein expression. |
2006 |
Chemotherapy |
pmid:17008791
|